InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-7.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Abingworth LLP. Insider active across 3 companies, notably Vera Therapeutics, Inc.. Aggregated, 5 filings have been published. Split: 1 buy · 0 sell. History available since 28 January 2022. The latest transaction was disclosed on 28 January 2022 (X). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
7,720,000 sharesCommon StockSEC:0000905718-22-000523:0
Ideal exit: 24 Dec 2022 (T+270)
287,471 shares@ US$13.2050.0% of flowCommon Stock, $0.001 par valueSEC:0000905718-22-000177:0
287,471 shares@ US$13.20100.0% of flowCommon Stock, $0.001 par valueSEC:0000905718-22-000177
2,187,504 sharesClass A Common StockSEC:0000905718-21-000712:0
2,187,504 sharesClass A Common StockSEC:0000905718-21-000712
5 of 5 declarations
About Abingworth LLP
Abingworth LLP is a director and insider for Vera Therapeutics, Inc., Sierra Oncology, Inc., and Soleno Therapeutics INC.
